Objective: to analyze the effect of Compound Changpu Yizhi Decoction combined with Nimodipine in the treatment of mild cognitive dysfunction after stroke. Methods: a total of 70 patients with mild cognitive impairment...Objective: to analyze the effect of Compound Changpu Yizhi Decoction combined with Nimodipine in the treatment of mild cognitive dysfunction after stroke. Methods: a total of 70 patients with mild cognitive impairment after stroke were selected from our hospital from July 2018 to July 2019, and randomly divided into 2 groups with 35 patients in each group in the digital table. Patients in the control group were treated with Nimodipine, while patients in the observation group were additionally treated with Compound Changpu Yizhi Decoction. Results: the scores of Montreal Cognitive Assessment Scale (MOCA), Simple Mental Status Checklist (MMSE) and ADL of daily living ability in 2 groups before treatment were compared (P > 0.05), while the above three scores were increased in 2 groups after treatment, and the scores of observation group were significantly higher than control group (P < 0.05). The total effective rate of observation group was 85.71% (30/35) higher than that of control group (65.71%, 23/35), P < 0.05. Conclusion: Nimodipine combined with Compound Changpu Yizhi Decoction has a definite effect on the treatment of mild cognitive dysfunction after stroke, which is beneficial to improve the cognitive function of patients and promote the ability of daily living activities of patients. Therefore, it is worthy of promotion and application.展开更多
文摘Objective: to analyze the effect of Compound Changpu Yizhi Decoction combined with Nimodipine in the treatment of mild cognitive dysfunction after stroke. Methods: a total of 70 patients with mild cognitive impairment after stroke were selected from our hospital from July 2018 to July 2019, and randomly divided into 2 groups with 35 patients in each group in the digital table. Patients in the control group were treated with Nimodipine, while patients in the observation group were additionally treated with Compound Changpu Yizhi Decoction. Results: the scores of Montreal Cognitive Assessment Scale (MOCA), Simple Mental Status Checklist (MMSE) and ADL of daily living ability in 2 groups before treatment were compared (P > 0.05), while the above three scores were increased in 2 groups after treatment, and the scores of observation group were significantly higher than control group (P < 0.05). The total effective rate of observation group was 85.71% (30/35) higher than that of control group (65.71%, 23/35), P < 0.05. Conclusion: Nimodipine combined with Compound Changpu Yizhi Decoction has a definite effect on the treatment of mild cognitive dysfunction after stroke, which is beneficial to improve the cognitive function of patients and promote the ability of daily living activities of patients. Therefore, it is worthy of promotion and application.
